Huakang Biomedical Holdings Company Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.3900
+0.0100 (2.63%)
Aug 29, 2025, 3:58 PM HKT
HKG:8622 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -4.75 | -4.16 | -5.78 | -3.08 | -4.22 | -11.63 | Upgrade |
Depreciation & Amortization | 2.57 | 2.66 | 2.5 | 2.75 | 2.69 | 2.86 | Upgrade |
Other Amortization | 0.67 | 0.68 | 0.68 | 0.39 | 0.26 | 0.33 | Upgrade |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.01 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 2.59 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.04 | Upgrade |
Stock-Based Compensation | - | - | - | - | - | 2.66 | Upgrade |
Provision & Write-off of Bad Debts | 0.09 | 0.09 | 1.41 | 0.37 | 0.64 | 0.79 | Upgrade |
Other Operating Activities | 1.57 | -0.45 | 0.03 | -0.72 | -0.26 | -0.78 | Upgrade |
Change in Accounts Receivable | -0.36 | -0.36 | -1.63 | -0.44 | -0.53 | -0.21 | Upgrade |
Change in Inventory | 0.68 | 0.68 | -0.49 | 1.05 | -1.63 | -0.06 | Upgrade |
Change in Accounts Payable | 0.03 | 0.03 | -0.19 | 0.11 | -0.73 | 0.42 | Upgrade |
Change in Unearned Revenue | 0.14 | 0.14 | -0.72 | -0.9 | 0.03 | 1.85 | Upgrade |
Change in Other Net Operating Assets | -2.26 | -2.26 | 3.77 | 1.76 | 1.38 | -2.79 | Upgrade |
Operating Cash Flow | -1.72 | -3.06 | -0.05 | 1.29 | -2.38 | -3.92 | Upgrade |
Capital Expenditures | -1.99 | -1.99 | -1.5 | -0.65 | -1.95 | -1.74 | Upgrade |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | - | 0.1 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -0.16 | -0.38 | -0.34 | Upgrade |
Investment in Securities | -5 | -5 | - | -1.9 | - | -0.04 | Upgrade |
Other Investing Activities | 5.25 | 0.35 | 0.34 | 0.4 | 0.18 | 0.19 | Upgrade |
Investing Cash Flow | 0.48 | -4.43 | -1.15 | -6.11 | -2.06 | -1.94 | Upgrade |
Short-Term Debt Issued | - | - | 1.44 | 1.31 | 0.1 | - | Upgrade |
Total Debt Issued | - | - | 1.44 | 1.31 | 0.1 | - | Upgrade |
Long-Term Debt Repaid | - | -1.2 | -0.88 | -1.29 | -1.47 | -1.11 | Upgrade |
Total Debt Repaid | -1.2 | -1.2 | -0.88 | -1.29 | -1.47 | -1.11 | Upgrade |
Net Debt Issued (Repaid) | -1.2 | -1.2 | 0.56 | 0.02 | -1.37 | -1.11 | Upgrade |
Issuance of Common Stock | 7.49 | 7.49 | 0.47 | 2.31 | - | - | Upgrade |
Other Financing Activities | -5.32 | - | - | - | - | - | Upgrade |
Financing Cash Flow | 0.98 | 6.3 | 1.02 | 2.32 | -1.37 | -1.11 | Upgrade |
Foreign Exchange Rate Adjustments | 0.34 | -0.25 | -0.19 | -0.41 | 0.06 | 0.12 | Upgrade |
Net Cash Flow | 0.07 | -1.44 | -0.37 | -2.9 | -5.74 | -6.85 | Upgrade |
Free Cash Flow | -3.71 | -5.05 | -1.55 | 0.64 | -4.33 | -5.67 | Upgrade |
Free Cash Flow Margin | -14.41% | -19.93% | -6.29% | 2.51% | -16.57% | -25.79% | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | 0.00 | -0.01 | -0.01 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.01 | - | Upgrade |
Cash Income Tax Paid | 0.01 | 0.01 | -0.19 | 0.48 | 0.36 | 0.86 | Upgrade |
Levered Free Cash Flow | 2.44 | -1.62 | -1.76 | -2.86 | -2.88 | -2.02 | Upgrade |
Unlevered Free Cash Flow | 2.51 | -1.57 | -1.73 | -2.82 | -2.81 | -1.97 | Upgrade |
Change in Working Capital | -1.77 | -1.77 | 0.75 | 1.57 | -1.49 | -0.79 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.